One of these studies, the Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes (CAROLINA), will also test whether linagliptin has a safer cardiovascular profile than the sulfonylurea glimepiride, providing further information related to the long-standing controversy regarding sulfonylurea safety, which was initially raised by the University Group Diabetes Program in the 1970s [9]
doi:10.2147/CCID.S127361 Study: Antioxidants like glutathione preserve collagen, reducing fine lines and wrinkles
The expectation is informed extrapolation, not a published headline
Furgiuele S, Descamps G, Cascarano L,Boucq A, Dubois C,Journe F,Saussez S
The quality and experience are the same across the entire catalog
The information is provided for educational and laboratory research awareness purposes only